HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased affinity and selectivity of enkephalin tripeptide (Tyr-D-Ala-Gly) dimers.

Abstract
The binding of alkylendiamide dimers of the three N-terminal residues of [D-Ala2,D-Leu5]enkephalin (DADL) to rat brain and Ng108-15 neuroblastoma-glioma cell membranes was compared with that of DADL, Tyr-D-Ala-Gly-NMe-Phe-Gly-ol (DAGO) and morphiceptin. Tritiated DADL and DAGO were used as labeled ligands for delta- and mu-receptors, respectively. Dimerization of the tripeptides resulted in dramatic increases in both mu and delta binding. The binding to mu-receptors showed two peaks at an alkyl chain length of n = 2 and approximately n = 16. In contrast, delta binding (NG108-15 cells) increased steadily with increasing chain length. The dimers with n less than 18 were mu-preferential, and the one with n = 2 showed the most dramatic increase in mu selectivity with a 400 fold higher affinity to mu- than to delta-receptors. For long-chain alkyl spacers the compounds became delta selective.
AuthorsR A Lutz, R A Cruciani, Y Shimohigashi, T Costa, S Kassis, P J Munson, D Rodbard
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 111 Issue 2 Pg. 257-61 (May 08 1985) ISSN: 0014-2999 [Print] Netherlands
PMID2990953 (Publication Type: Journal Article)
Chemical References
  • Enkephalins
  • Oligopeptides
  • Receptors, Opioid
  • Receptors, Opioid, delta
  • Receptors, Opioid, mu
Topics
  • Animals
  • Brain (metabolism)
  • Enkephalins (metabolism)
  • In Vitro Techniques
  • Male
  • Oligopeptides (metabolism)
  • Rats
  • Rats, Inbred Strains
  • Receptors, Opioid (metabolism)
  • Receptors, Opioid, delta
  • Receptors, Opioid, mu

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: